WO2010077062A3 - Preparation method of statin compound and benzothiazolyl sulfone compound used therein - Google Patents

Preparation method of statin compound and benzothiazolyl sulfone compound used therein Download PDF

Info

Publication number
WO2010077062A3
WO2010077062A3 PCT/KR2009/007881 KR2009007881W WO2010077062A3 WO 2010077062 A3 WO2010077062 A3 WO 2010077062A3 KR 2009007881 W KR2009007881 W KR 2009007881W WO 2010077062 A3 WO2010077062 A3 WO 2010077062A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
preparation
statin
benzothiazolyl
benzothiazolyl sulfone
Prior art date
Application number
PCT/KR2009/007881
Other languages
French (fr)
Other versions
WO2010077062A2 (en
Inventor
Hee Seock Kim
Won Jeoung Kim
Hee Cheol Kim
Jae Yi Sim
Seong Mi Cho
Eun Young Byun
Ji Young Jeon
Yoon Ju Lee
Kwee Hyun Suh
Gwan Sun Lee
Original Assignee
Hanmi Pharm. Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm. Co., Ltd. filed Critical Hanmi Pharm. Co., Ltd.
Publication of WO2010077062A2 publication Critical patent/WO2010077062A2/en
Publication of WO2010077062A3 publication Critical patent/WO2010077062A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/18—Nitrogen atoms not forming part of a nitro radical with hetero atoms attached to said nitrogen atoms, except nitro radicals, e.g. hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The inventive method comprising subjecting a novel benzothiazolyl sulfone compound to a reaction with an aldehyde to obtain a vinyl intermediate and removing the hydroxy and carboxy protective groups of the vinyl intermediate is simple and efficient in preparing a statin compound or a salt thereof which is useful for treating hyperlipemia.
PCT/KR2009/007881 2008-12-29 2009-12-29 Preparation method of statin compound and benzothiazolyl sulfone compound used therein WO2010077062A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0135857 2008-12-29
KR20080135857 2008-12-29

Publications (2)

Publication Number Publication Date
WO2010077062A2 WO2010077062A2 (en) 2010-07-08
WO2010077062A3 true WO2010077062A3 (en) 2010-11-04

Family

ID=42310379

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/007881 WO2010077062A2 (en) 2008-12-29 2009-12-29 Preparation method of statin compound and benzothiazolyl sulfone compound used therein

Country Status (2)

Country Link
KR (1) KR20100080432A (en)
WO (1) WO2010077062A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034901B2 (en) 2010-08-25 2015-05-19 Cadila Healthcare Limited Pitavastatin calcium and process for its preparation
EP3178812A1 (en) 2010-11-12 2017-06-14 Hetero Research Foundation Novel polymorphs of pitavastatin calcium
CN103313983B (en) * 2011-01-18 2016-06-29 中化帝斯曼制药有限公司荷兰公司 The method preparing statin compound in the presence of a base
CN103058925B (en) * 2011-11-02 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 A kind of preparation method of Pitavastatin Calcium
WO2013098773A1 (en) * 2011-12-28 2013-07-04 Dr. Reddy's Laboratories Limited Crystalline forms of pitavastatin calcium
CN103508946B (en) * 2012-06-20 2016-06-29 徐州万邦金桥制药有限公司 The preparation method of Pitavastatin Calcium
ITVI20130039A1 (en) 2013-02-20 2014-08-21 F I S Fabbrica Italiana Sint I S P A PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR STATIN SYNTHESIS
WO2014203045A1 (en) 2013-06-20 2014-12-24 Lupin Limited A novel, green and cost effective process for synthesis of tert-butyl (3r,5s)-6-oxo-3,5-dihydroxy-3,5-o-isopropylidene-hexanoate
CN109574938B (en) * 2017-09-28 2022-04-22 安徽省庆云医药股份有限公司 Method for synthesizing rosuvastatin sodium
CN109574998B (en) * 2017-09-28 2022-03-08 安徽省庆云医药股份有限公司 Synthetic method of pitavastatin calcium intermediate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004450A1 (en) * 2001-07-06 2003-01-16 Ciba Specialty Chemicals Holding Inc. Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
US6844437B1 (en) * 1999-02-17 2005-01-18 Astrazeneca Ab Process for the production of tert-butyl (E)-(6-[2-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsufonyl)amino]pyrimidin-5-yl]vinyl]4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
WO2007125547A2 (en) * 2006-05-03 2007-11-08 Manne Satyanarayana Reddy Novel process for statins and its pharmaceutically acceptable salts thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844437B1 (en) * 1999-02-17 2005-01-18 Astrazeneca Ab Process for the production of tert-butyl (E)-(6-[2-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsufonyl)amino]pyrimidin-5-yl]vinyl]4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
WO2003004450A1 (en) * 2001-07-06 2003-01-16 Ciba Specialty Chemicals Holding Inc. Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
WO2007125547A2 (en) * 2006-05-03 2007-11-08 Manne Satyanarayana Reddy Novel process for statins and its pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
WO2010077062A2 (en) 2010-07-08
KR20100080432A (en) 2010-07-08

Similar Documents

Publication Publication Date Title
WO2010077062A3 (en) Preparation method of statin compound and benzothiazolyl sulfone compound used therein
WO2011005672A3 (en) Methods for treating carbonate hydrocarbon-bearing formations with fluorinated amphoteric compounds
EP2295536A4 (en) Microorganism capable of producing improved polyhydroxyalkanoate and method of producing polyhydroxyalkanoate by using the same
AU2009262289A8 (en) Various methods and apparatus for solar assisted chemical and energy processes
EP2231992A4 (en) Method and apparatus to improve design, manufacture, performance and/or use of well tools
WO2009156608A3 (en) Article having antifouling properties for aquatic and particularly sea use
WO2006128009A3 (en) Supplement composition and method of use for enhancement of dna repair process
WO2012076985A8 (en) Granzyme b inhibitor compositions, methods and uses for promoting wound healing
HK1155787A1 (en) Grip extension linkage to provide gripping tool with improved operational range, and method of use of the same
WO2010021738A3 (en) Method for producing double-crosslinked collagen
WO2009152210A3 (en) Coumarin compounds and their use for treating cancer
PL2271764T3 (en) Method for the enzymatic production of fatty alcohol and/or fatty acid
ZA201102547B (en) Compositions and methods for the rapid growth and detection of microorganisms
WO2012068356A3 (en) Compositions and methods for improving the appearance of facial pores
WO2007117453A3 (en) Radiosynthesis as an alternative energy utilization process in melanized organisms and uses thereof
WO2008117658A1 (en) Method of covering soil
WO2008093843A1 (en) Instant noodle and method for production thereof
MY173770A (en) Process for producing diacylglycerol-rich fat or oil
WO2010027323A3 (en) Corrosion inhibition
WO2009106645A3 (en) Method for in-process decontamination in food preparation and processing and for reducing microbial content in cosmetics, pharmaceuticals, daily-care products and animal and plant food and for treatment of surfaces
EP1940522B8 (en) Part intended to be gripped manually, and method of producing same
EP2275400A4 (en) Process for producing acrylic acid, and process for producing hydrophilic resin and process for producing water absorptive resin using the process
WO2007019048A3 (en) High ph compositions
EP2310258A4 (en) System to protect objects from growth on surfaces submerged into water
TW200732292A (en) A method of treating an aldehyde mixture, use of the treated aldehyde, and an alcohol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09836383

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09836383

Country of ref document: EP

Kind code of ref document: A2